What Are Valganciclovir Side Effects for Congenital CMV?

The most important side effect to monitor during valganciclovir treatment for symptomatic congenital CMV (cCMV) is a drop in a specific type of white blood cell ^[1]. This condition is called neutropenia. While the standard six-month valganciclovir protocol is often prescribed for infants with symptomatic cCMV (particularly those with central nervous system involvement), the medication requires careful observation. To ensure your baby’s safety, their care team will order regular laboratory monitoring to check their cell counts, kidney function, and liver function ^[2]. Based on these tests, the doctor may occasionally hold the medication or adjust the dosage.

While taking an antiviral medication for six months is a major commitment, understanding the potential side effects and exactly what to watch for can help you feel prepared and in control.

Neutropenia: The Primary Side Effect

Valganciclovir works by stopping the CMV virus from multiplying, but it can also suppress the bone marrow’s ability to make new blood cells. The most common and significant result is neutropenia, which is a low level of neutrophils (the white blood cells that defend the body against bacterial infections).

In one study of infants receiving a six-month valganciclovir protocol, 33% experienced an Absolute Neutrophil Count (ANC) below 500/mm³ at some point during treatment ^[3]. Neutropenia can develop at any time during the six months, not just in the first few weeks, which is why ongoing monitoring is so important ^[3][4]. Premature babies or those who already have lower white blood cell counts before starting treatment may be at a higher risk ^[5].

Because an infant with neutropenia has a temporarily compromised immune system, it is vital to monitor them for illness. Seek immediate medical attention if your baby develops a fever. For an infant under 3 months of age, a rectal temperature of 38.0°C (100.4°F) or higher is typically considered a medical emergency. You should also call your doctor immediately for other serious signs of illness, such as marked lethargy (extreme sleepiness), difficulty breathing, poor feeding, or fewer wet diapers.

Other Potential Side Effects

While neutropenia is the primary concern, valganciclovir can cause other side effects that require monitoring:

• Anemia (Low Red Blood Cells): Valganciclovir can reduce the number of red blood cells, which carry oxygen. In a study of infants on a one-year protocol, 7.5% experienced a drop in hemoglobin below 9 g/dL, and a small number required a blood transfusion ^[6]. Signs of anemia include unusual paleness (pallor), excessive fatigue, and poor feeding.
• Thrombocytopenia (Low Platelets): Platelets help the blood clot. While cCMV itself can cause low platelets, the medication can also suppress platelet production ^[2]. Watch for and immediately report new, unexplained bruising, tiny red/purple spots on the skin (petechiae), bleeding from the nose or gums, or blood in the stool or urine.
• Kidney Function Changes: The kidneys clear valganciclovir from the body. If the kidneys aren’t filtering well, the drug can build up in the bloodstream, increasing the risk of bone marrow suppression ^[7][8]. This is especially important for premature infants whose kidneys are still maturing ^[9].
• Liver Function Changes: Liver enzymes and bilirubin are monitored to detect any signs of liver injury or cholestasis (reduced bile flow) ^[2]. Note that jaundice (yellowing of the skin) or dark urine can be caused by the cCMV infection itself, but should always be reported to your doctor ^[10].

The Necessity of Regular Blood Draws

While watching your baby for symptoms is essential, regular laboratory monitoring is crucial to catch changes in blood counts or organ function before they cause visible problems. There is no single universal schedule, but your pediatric infectious disease specialist will likely order frequent tests during the first few weeks, and then potentially space them out if your baby’s body handles the drug well ^[3].

At these lab visits, the care team will check:

• Complete Blood Count (CBC) with Differential: This measures neutrophils (ANC), red blood cells (hemoglobin), and platelets ^[2].
• BUN and Creatinine: These markers check how well the kidneys are filtering waste ^[11][2].
• Liver Function Tests (LFTs): To ensure the liver is not experiencing injury or inflammation ^[2].

Dosage Adjustments and Pauses

It is very common for an infant’s valganciclovir dosage to change over the six months. This happens for two main reasons:

1. Managing Side Effects: If your baby develops severe neutropenia or other significant lab abnormalities, the doctor will likely “hold” (pause) the medication until the bone marrow recovers ^[5]. Once safe, they may restart the medication, sometimes at a lower dose. Never stop, pause, or adjust the medication on your own.
2. Growth and Development: Valganciclovir is dosed based on a combination of body weight (or body surface area) and kidney function ^[12]. As your baby grows rapidly, their dose will need to be recalculated regularly by the medical team to ensure they are getting enough medicine to fight the virus without risking toxicity ^[8]. Do not attempt to change the dose yourself based on a home weight.